rs1555403597
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PVS1PM2
The NM_031427.4(DNAL1):c.533-2A>G variant causes a splice acceptor, intron change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_031427.4 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Publications
- primary ciliary dyskinesia 16Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: PanelApp Australia, Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| DNAL1 | NM_031427.4 | c.533-2A>G | splice_acceptor_variant, intron_variant | Intron 7 of 7 | ENST00000553645.7 | NP_113615.2 | ||
| DNAL1 | NM_001201366.2 | c.416-2A>G | splice_acceptor_variant, intron_variant | Intron 8 of 8 | NP_001188295.1 | |||
| DNAL1 | XM_017021679.3 | c.416-2A>G | splice_acceptor_variant, intron_variant | Intron 8 of 8 | XP_016877168.1 | |||
| DNAL1 | XM_024449715.2 | c.416-2A>G | splice_acceptor_variant, intron_variant | Intron 8 of 8 | XP_024305483.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1425066Hom.: 0 Cov.: 28 AF XY: 0.00 AC XY: 0AN XY: 705898
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia 16 Uncertain:1
The current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in DNAL1 cause disease. Therefore, this variant has been classified as a Variant of Uncertain Significance. This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a DNAL1-related disease. This sequence change affects an acceptor splice site in intron 7 of the DNAL1 gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at